663 related articles for article (PubMed ID: 19001816)
1. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
Seveso M; Bosio E; Ancona E; Cozzi E
Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
[TBL] [Abstract][Full Text] [Related]
2. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
Cardarelli F; Pascual M; Tolkoff-Rubin N; Delmonico FL; Wong W; Schoenfeld DA; Zhang H; Cosimi AB; Saidman SL
Transpl Int; 2005 May; 18(5):532-40. PubMed ID: 15819801
[TBL] [Abstract][Full Text] [Related]
5. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
Saidman S
Transplant Proc; 2007 Apr; 39(3):744-6. PubMed ID: 17445587
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
[TBL] [Abstract][Full Text] [Related]
7. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry.
Piazza A; Poggi E; Ozzella G; Borrelli L; Scornajenghi A; Iaria G; Tisone G; Adorno D
Clin Transpl; 2006; ():323-36. PubMed ID: 18365387
[TBL] [Abstract][Full Text] [Related]
9. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.
Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D
Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of anti-HLA donor-specific antibodies detected by Luminex assay in the development of rejection after renal transplantation.
Caro-Oleas JL; González-Escribano MF; Gentil-Govantes MÁ; Acevedo MJ; González-Roncero FM; Blanco GB; Núñez-Roldán A
Transplantation; 2012 Aug; 94(4):338-44. PubMed ID: 22814330
[TBL] [Abstract][Full Text] [Related]
12. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up.
Lachmann N; Terasaki PI; Schönemann C
Clin Transpl; 2006; ():171-99. PubMed ID: 18365377
[TBL] [Abstract][Full Text] [Related]
15. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
16. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.
Akalin E; Dinavahi R; Dikman S; de Boccardo G; Friedlander R; Schroppel B; Sehgal V; Bromberg JS; Heeger P; Murphy B
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1261-7. PubMed ID: 17942771
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of C4d in renal allograft biopsies in different clinical settings: absence of C4d in grafts from non-heart-beating donors.
Crespo M; Sole M; Arostegui JL; Mila J; Martorell J; Oppenheimer F
Transplant Proc; 2005 Nov; 37(9):3688-9. PubMed ID: 16386506
[TBL] [Abstract][Full Text] [Related]
18. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
[TBL] [Abstract][Full Text] [Related]
19. Pathology of chronic humoral rejection.
Colvin RB
Contrib Nephrol; 2009; 162():75-86. PubMed ID: 19001815
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
